Asset / Drug

GE

Drug and asset intelligence for GE with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Stage: Development stage unavailable

Recent signals(1)

RegulatoryJune 29, 2026

GE HealthCare Issues Correction for Infant Resuscitation Systems Due to Oxygen Concentration Risk

GE HealthCare has issued a correction for Giraffe and Panda infant resuscitation systems due to a potential loosening of the air-oxygen blender knob shaft, which may affect oxygen delivery.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Therapeutic areas

Medical Devices →

Pediatrics →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.